精彩推荐:青光眼 白内障 近视 远视 散光 斜视弱视 角膜溃疡 角膜炎 沙眼 眼外伤 更多疾病
大众频道
专业频道
时尚频道
互动频道
疾 病 | 保 健 | 爱眼动态 | 名医名院
知 识 | 美 食 | 自检自测 | 爱眼纪事
资 讯 | 临 床 | 学 术 | 文 献
图 谱 | 医 患 | 继 教 | 家 园
五官之美 | 整 形 | 美 容
眼镜一族 | 妆 容 | 图 库
眼科在线 | 预留位置
眼科知道 | 在线咨询
  当前位置:当前位置: 中华眼科在线 → 医学频道 → 医学英语 → 正文 切换到繁體中文 用户登录 新用户注册
Neovascularization profile in rat allogenic penetrating keratoplasty

http://www.cnophol.com 2009-7-2 11:16:35 中华眼科在线

    【摘要】  To observe the neovascularization process with no intervention in rat allogenic penetrating keratoplasty. METHODS: Allogenic penetrating keratoplasties were successfully performed in 34 female SPF SD rats with no intervention after operations. Corneal neovascularization(CNV) process was noted on day 4, 7, 15 and 30 with operating microscope. The vascular area surface was calculated using the formula C/12×3.14×[r2(rI)2].RESULTS: CNV was noted in 29 out of 34 rats (85%). Firstly, the new vessels distributed around the cornea like a brush then gradually extended towards the center. The vessels were distorted and massive with branched tails, they continued growing to reticulated veins in peak time then gradually atrophied. The average neovascularization area (SE) on day 4, 7, 15 and 30 was 11.8±3.5mm2, 18.5±4.0mm2,14.4±4.3mm2 and 6.0±1.8mm2 respectively and 12.7±1.9mm2 in total. The average percentage that new vessels accounting the whole cornea area(SE) was 30.8%±8.7%, 65.3%±12.8%, 59.4%±14.5%,36.2%±10.9% and 48.7%±6.4% in total.
CONCLUSION: In rat allogenic penetrating keratoplasties without intervention, CNV presented on day 4 and reached the maximum area on day 7. Then the vessels gradually atrophied, about 50% of the maximum area still remained on day 30.

    【关键词】  rat allogenic penetrating keratoplasty neovascularization

  Neovascularization profile in rat allogenic penetrating keratoplasty. Int J Ophthalmol(Guoji Yanke Zazhi)2009;9(5):820823

  INTRODUCTION

  Corneal neovascularization (CNV) after keratoplasty not only makes cornea lose transparency and impair vision directly, but also promotes the rejection and lead to failure of cornea transplantation in the end. However, inhibition of CNV has always been a difficult and hot spot in ophthalmic research. In this article, we observe and analyze the CNV process in rat allogenic penetrating keratoplasty model. Through the development and apoptosis of it, we hope to get some hints on CNV inhibition.

  MATERIALS AND METHODS

  Materials  All experiments were performed on 68 week old female SD rat, weighting 180200g. There were 51 rats in total, seventeen as donors and 34 as recipients. All animals were purchased from Nanfang Hospital Experimental Animal Center.

  Methods  Pentobarbital solution(30g/L) was injected into rats peritoneal cavity for anesthesia. The averange dose was 0.32mL (range from 0.1mL to 0.5mL). When the rat fell asleep, the eyelids of right eye were wiped twice with alcohol swab and then conjunctival sac was washed with 2g/L liquor nitrofurazoni.Average dose of 0.04mL lidocaine solution 20g/L(range from 0.01mL to 0.2mL) was injected into the muscle pyramid along the orbital wall inward towards the optic foramen. Digital pressure was applied for 35 minutes to prevent bleeding.

  Allogenic Penetrating Keratoplasty
Donor preparation  Both corneas of donor rat were used in the experiment. When rat stopped winking after anesthesia, the eye was fixed with a forceps. A 3.75mm diameter corneal trephine was applied on the centre of cornea and rotated clockwise and anticlockwise up to 2/3 of total thickness of cornea. Then, the anterior chamber was opened with a triangular shaped surgical blade and sodium hyaluronate was injected into anterior chamber. The corneal button was cut with vanas scissor. The donor corneal button was kept in a mixture of ringers solution and sodium hyaluronate gel for 20 minutes.

  Recipient preparation  Keratoplasty procedure was performed in right eye only in all the rats. The procedure was the same as donor rat, but a 3.25mm diameter corneal trephine was used to take out the corneal button and sodium hyaluronate gel was injected into anterior chamber to replace the aqueous.
Penetrating keratoplasty  The corneal graft was fixed in placed by interrupted sutures, eight sutures per eye(needle arc 3/8·0.7×4,11/0 nylon monofilament nonabsorbable suture, Ningbo Medical Suture Needle Factory).The sodium hyaluronate was washed with saline and replaced with sterile air.

  Postopeartive Followup  After operation, secretions in conjunctiva sac were washed with saline everyday. The new vessels growth and change was observed with operating microscope on day 4, 8, 15 and 30. The vascular area surface  was calculated using the formula C/12×3.14×[r2(rI)2]. In this formula, C was the clock hours CNV accounted, r was cornea radius (mm) and I was the vertical length (mm) that CNV extened from limbus to cornea center. Percentage that CNV accounting the whole cornea area was calculated.

  Statistical Analysis  Normality test was carried out with KolmogorovSmirnov test, when P>0.05 data was considered distributed normally.Statistical values of CNV area and percentage that CNV accounting the whole cornea area were calculated.

  RESULTS

  Neovascularization Rate  Penetrating keratoplasty was successfully performed in the right eye. Two rats were excluded since one died and the others document was not completed. The rest 34 rats were observed until 30 days after operation and 29 of them had growth of CNV, which accounted 85% of the total. Only 3 rats did not show any CNV, which accounted only 15%.
Appearance of Neovascularization  Conjunctive vessel extending towards the limbus expanded significantly and divided into several branches(Figure 1). At the beginning, CNV surrounded the limbus like the hair of a brush and it was quite difficult to identify every vessel clearly(Figure 2). Then some of vessels gradually thickened and distorted, with branch liked tails(Figure 3). The vessels extended from the limbus towards the centre of cornea and gradually invaded the donor cornea (Figure 4), which looked like dense reticulum and invaded the whole cornea (Figure 5).

  Corneal Neovascularization Area  KolmogorovSmirnov Normality test of CNV area on day 4,7,15 and 30 after keratoplasty showed P values>0.200 (for all the days individually), on the whole the P value was 0.126. Therefore, CNV area data were considered distributed normally(Figure 6). The CNV area on different observation days was different (Figure 7).
Normality Test of Percentages that Corneal Neovascularization Accounting the Whole Cornea Area  KolmogorovSmirnov Normality test of CNV accounting the whole cornea area on day 4,7,15 and 30 after keratoplasty showed P values 0.200,0.180,0.156 and 0.200 respectively; on the whole the P value was 0.193. Therefore, CNV area data were considered distributed normally(Figure 8). The CNV accounting the whole cornea area percentage on different observation days was also different (Figure 9).

  DISCUSSION

  CNV makes cornea lose transparency and affects vision directly. However, new vessles invading into cornea will never disappear but only degenerate into ghost vessels[1] Therefore, prevention of new vessels formation is very important. CNV also lead to the failure of keratoplasty. Recently some researchers think that CNV triggered by wound repairing and inflammation mechanism maybe the immediate cause of transplantation rejection [2]. Though cornea is recognized to be immune privileged for a long time, great deal of clinical researches have proved that the most important reason of corneal transplantation failure still is nonreversible rejection. Corneal transplantations prospective efficacy is not as optimistic as we used to think. Even though transplantations successive rate is quite high in short term,graft survival area exceeding 90% one year after operation is not common in clinical practice [1] . Williams and Coster [2] reported that eyes which develop rejection must have neovascularization and inflammation. The molecular mechanism of "vascular privilege" and "immune privilege" are overlapped in many cases [3]. Neovascularization in corneal transplantation should be considered to be even more important because it leads to rejection phenomenon of the graft.

  Profuse capillary plexuses around the limbus are originated from ciliary arteries, which come from ophthalmic arteries. The capillary plexuses can generate CNV from angiogenesis [4]. With stimulation of angiogenesis factors such as inflammation factors, the balance between vascular growth factor and inhibiting factor is broken. Vascular endothelial cells fill up the vessels increasing their permeability.With the effect of many enzymes, vascular basilar membrane disaggregates, endothelial cells exert pseudopodias through the gap of basilar membrane towards vascular stimulating factors direction. The endothelial cells go forward continuously and form a two poles aligned cell column. While at the same time, cell columns anterior extremity displays branching and has blood flow with the formation of lumen. In the end, leucocytes in surrounding tissues decorates the new vessels; pericytes originated from parent vessles cover the new vessles and form basilar membrane. The new vessles become matured later [5].

  CNV is divided into superficial NV and deep stromal NV according to their different positions in cornea. The superficial NV originate form superficial peripheral pannus and manifest as single or multiple distorted vessles with branched liked tails and extend into superficial stroma under corneal epithelium. It is caused by chronic superficial irritation and is commonly seen in corneal inflammation and anterior segment operations. Most CNV are of this kind ( Figure 3). Deep stromal NV can develop in any stroma level. The vessels are straight and branched, acompanied by nerve fibers occasionly. It is common in scleritis, tuberculosis and syphilis patients eyes[46].

[1] [2] 下一页

(来源:首席医学网)(责编:zhanghui)

发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
  • 下一条信息: 没有了
  • 更多关于(眼睛,中华眼科在线,rat,allogenic,penetrating,keratoplasty,neovascularization)的信息
      热门图文

    黑眼圈超详细解决方案

    让眼睛抓住青春“不放

    今夏最抢镜的火辣活力

    学化性感眼妆让诱惑电
      健康新看点
      健康多视点
      图话健康

    Copyright © 2007 中华眼科在线 网站备案序列号: 京ICP备08009675号
    本网站由五景药业主办 北京金鼎盛世医学传媒机构负责运营 国家医学教育发展中心提供学术支持
    服务电话:010-63330565 服务邮箱: [email protected]